Germany
Japan
United Kingdom
China
STAT4 mouse monoclonal capture antibody, validated for ELISA and Luminex assays
| Applications | ELISA, LMNX |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Matched ELISA Pair | TA700183, TA700192, TA700193, TA700194, TA700195 |
Antibodies
View as table Download
USD 458.00
In Stock
Active filters
Conjugates
- Unconjugated
Assay Platforms
- Luminex
Families
- Transcription Factors
Filter by
Category
Target Symbol
Reactivities
Applications
Antibody Hosts
Clonalities
Assay Types
Pathways
- Pathways in cancer (15)
- Wnt signaling pathway (14)
- MAPK signaling pathway (11)
- Colorectal cancer (10)
- ErbB signaling pathway (10)
- Focal adhesion (8)
- Toll-like receptor signaling pathway (8)
- Jak-STAT signaling pathway (7)
- Acute myeloid leukemia (6)
- Chronic myeloid leukemia (6)
- Endometrial cancer (6)
- Thyroid cancer (6)
- Renal cell carcinoma (5)
- T cell receptor signaling pathway (5)
- TGF-beta signaling pathway (5)
- Adherens junction (4)
- Allograft rejection (4)
- Arrhythmogenic right ventricular cardiomyopathy (ARVC) (4)
- B cell receptor signaling pathway (4)
- Basal cell carcinoma (4)
- Epithelial cell signaling in Helicobacter pylori infection (4)
- GnRH signaling pathway (4)
- Graft-versus-host disease (4)
- Leukocyte transendothelial migration (4)
- Maturity onset diabetes of the young (4)
- Melanogenesis (4)
- Neurotrophin signaling pathway (4)
- Notch signaling pathway (4)
- Pathogenic Escherichia coli infection (4)
- Prostate cancer (4)
- Systemic lupus erythematosus (4)
- Tight junction (4)
- Type I diabetes mellitus (4)
- Autoimmune thyroid disease (3)
- Cell adhesion molecules (CAMs) (3)
- Viral myocarditis (3)
- Adipocytokine signaling pathway (2)
- Alzheimer's disease (2)
- Amyotrophic lateral sclerosis (ALS) (2)
- Apoptosis (2)
- Bladder cancer (2)
- Cell cycle (2)
- Cytokine-cytokine receptor interaction (2)
- Small cell lung cancer (2)
- Asthma (1)
- Dilated cardiomyopathy (1)
- Fc epsilon RI signaling pathway (1)
- Hematopoietic cell lineage (1)
- Hypertrophic cardiomyopathy (HCM) (1)
- NOD-like receptor signaling pathway (1)
- Natural killer cell mediated cytotoxicity (1)
- RIG-I-like receptor signaling pathway (1)
- Type II diabetes mellitus (1)